Impact of COVID-19 Outbreak on Recombinant Hepatitis B Vaccine, Global Market Research Report 2020
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Hepatitis B Vaccine industry.
Based on our recent survey, we have several different scenarios about the Recombinant Hepatitis B Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Hepatitis B Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Recombinant Hepatitis B Vaccine market is segmented into
The Recombinant Hepatitis B Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Recombinant Hepatitis B Vaccine market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Recombinant Hepatitis B Vaccine market include:
Based on our recent survey, we have several different scenarios about the Recombinant Hepatitis B Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Hepatitis B Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Recombinant Hepatitis B Vaccine market is segmented into
- 10mcg/ml
- 10mcg/0.5ml
- Newborn
- Primary School Students
- Adult
The Recombinant Hepatitis B Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Recombinant Hepatitis B Vaccine market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Recombinant Hepatitis B Vaccine market include:
- Merck
- GlaxoSmithKline Plc
- Pfizer Inc.
- Sanofi Pasteur
- CSL Limited
- Emergent Biosolutions
- Serum Institute of India
- Johnson & Johnson
- Hualan Biological Engineering
- NCPC
- China National Biotec Group
- Dalian Hissen Bio-pharm
- Beijing Tiantan Biological
1 RECOMBINANT HEPATITIS B VACCINE MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Hepatitis B Vaccine
1.2 Covid-19 Implications on Recombinant Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Covid-19 Implications on Recombinant Hepatitis B Vaccine Segment by Application
1.3.1 Recombinant Hepatitis B Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Covid-19 Implications on Global Recombinant Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hepatitis B Vaccine Revenue 2015-2026
1.4.2 Global Recombinant Hepatitis B Vaccine Sales 2015-2026
1.4.3 Recombinant Hepatitis B Vaccine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Recombinant Hepatitis B Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Recombinant Hepatitis B Vaccine Industry
1.5.1.1 Recombinant Hepatitis B Vaccine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Recombinant Hepatitis B Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Recombinant Hepatitis B Vaccine Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL RECOMBINANT HEPATITIS B VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Recombinant Hepatitis B Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Hepatitis B Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Recombinant Hepatitis B Vaccine Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON RECOMBINANT HEPATITIS B VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.2 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.2 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Hepatitis B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.2 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.2 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.2 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL RECOMBINANT HEPATITIS B VACCINE HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Recombinant Hepatitis B Vaccine Price Market Share by Type (2015-2020)
4.4 Global Recombinant Hepatitis B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL RECOMBINANT HEPATITIS B VACCINE HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN RECOMBINANT HEPATITIS B VACCINE BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description, Business Overview and Total Revenue
6.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GlaxoSmithKline Plc Products Offered
6.2.5 GlaxoSmithKline Plc Recent Development
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description, Business Overview and Total Revenue
6.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Inc. Products Offered
6.3.5 Pfizer Inc. Recent Development
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Pasteur Products Offered
6.4.5 Sanofi Pasteur Recent Development
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description, Business Overview and Total Revenue
6.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 CSL Limited Products Offered
6.5.5 CSL Limited Recent Development
6.6 Emergent Biosolutions
6.6.1 Emergent Biosolutions Corporation Information
6.6.2 Emergent Biosolutions Description, Business Overview and Total Revenue
6.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Emergent Biosolutions Products Offered
6.6.5 Emergent Biosolutions Recent Development
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description, Business Overview and Total Revenue
6.6.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Serum Institute of India Products Offered
6.7.5 Serum Institute of India Recent Development
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Johnson & Johnson Products Offered
6.8.5 Johnson & Johnson Recent Development
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Corporation Information
6.9.2 Hualan Biological Engineering Description, Business Overview and Total Revenue
6.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hualan Biological Engineering Products Offered
6.9.5 Hualan Biological Engineering Recent Development
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description, Business Overview and Total Revenue
6.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 NCPC Products Offered
6.10.5 NCPC Recent Development
6.11 China National Biotec Group
6.11.1 China National Biotec Group Corporation Information
6.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 China National Biotec Group Products Offered
6.11.5 China National Biotec Group Recent Development
6.12 Dalian Hissen Bio-pharm
6.12.1 Dalian Hissen Bio-pharm Corporation Information
6.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Dalian Hissen Bio-pharm Products Offered
6.12.5 Dalian Hissen Bio-pharm Recent Development
6.13 Beijing Tiantan Biological
6.13.1 Beijing Tiantan Biological Corporation Information
6.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Beijing Tiantan Biological Products Offered
6.13.5 Beijing Tiantan Biological Recent Development
7 RECOMBINANT HEPATITIS B VACCINE MANUFACTURING COST ANALYSIS
7.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
7.4 Recombinant Hepatitis B Vaccine Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Recombinant Hepatitis B Vaccine Distributors List
8.3 Recombinant Hepatitis B Vaccine Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Recombinant Hepatitis B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Type (2021-2026)
10.2 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Application (2021-2026)
10.3 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Region (2021-2026)
10.4 North America Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.5 Europe Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Recombinant Hepatitis B Vaccine
1.2 Covid-19 Implications on Recombinant Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Covid-19 Implications on Recombinant Hepatitis B Vaccine Segment by Application
1.3.1 Recombinant Hepatitis B Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Covid-19 Implications on Global Recombinant Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hepatitis B Vaccine Revenue 2015-2026
1.4.2 Global Recombinant Hepatitis B Vaccine Sales 2015-2026
1.4.3 Recombinant Hepatitis B Vaccine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Recombinant Hepatitis B Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Recombinant Hepatitis B Vaccine Industry
1.5.1.1 Recombinant Hepatitis B Vaccine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Recombinant Hepatitis B Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Recombinant Hepatitis B Vaccine Players to Combat Covid-19 Impact
2 COVID-19 IMPLICATIONS ON GLOBAL RECOMBINANT HEPATITIS B VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Recombinant Hepatitis B Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Hepatitis B Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Recombinant Hepatitis B Vaccine Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON RECOMBINANT HEPATITIS B VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.2 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.2 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Hepatitis B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.2 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.2 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.2 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL RECOMBINANT HEPATITIS B VACCINE HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Recombinant Hepatitis B Vaccine Price Market Share by Type (2015-2020)
4.4 Global Recombinant Hepatitis B Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL RECOMBINANT HEPATITIS B VACCINE HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN RECOMBINANT HEPATITIS B VACCINE BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description, Business Overview and Total Revenue
6.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GlaxoSmithKline Plc Products Offered
6.2.5 GlaxoSmithKline Plc Recent Development
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description, Business Overview and Total Revenue
6.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Inc. Products Offered
6.3.5 Pfizer Inc. Recent Development
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Pasteur Products Offered
6.4.5 Sanofi Pasteur Recent Development
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description, Business Overview and Total Revenue
6.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 CSL Limited Products Offered
6.5.5 CSL Limited Recent Development
6.6 Emergent Biosolutions
6.6.1 Emergent Biosolutions Corporation Information
6.6.2 Emergent Biosolutions Description, Business Overview and Total Revenue
6.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Emergent Biosolutions Products Offered
6.6.5 Emergent Biosolutions Recent Development
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description, Business Overview and Total Revenue
6.6.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Serum Institute of India Products Offered
6.7.5 Serum Institute of India Recent Development
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Johnson & Johnson Products Offered
6.8.5 Johnson & Johnson Recent Development
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Corporation Information
6.9.2 Hualan Biological Engineering Description, Business Overview and Total Revenue
6.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hualan Biological Engineering Products Offered
6.9.5 Hualan Biological Engineering Recent Development
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description, Business Overview and Total Revenue
6.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 NCPC Products Offered
6.10.5 NCPC Recent Development
6.11 China National Biotec Group
6.11.1 China National Biotec Group Corporation Information
6.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 China National Biotec Group Products Offered
6.11.5 China National Biotec Group Recent Development
6.12 Dalian Hissen Bio-pharm
6.12.1 Dalian Hissen Bio-pharm Corporation Information
6.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Dalian Hissen Bio-pharm Products Offered
6.12.5 Dalian Hissen Bio-pharm Recent Development
6.13 Beijing Tiantan Biological
6.13.1 Beijing Tiantan Biological Corporation Information
6.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Description, Business Overview and Total Revenue
6.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Beijing Tiantan Biological Products Offered
6.13.5 Beijing Tiantan Biological Recent Development
7 RECOMBINANT HEPATITIS B VACCINE MANUFACTURING COST ANALYSIS
7.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
7.4 Recombinant Hepatitis B Vaccine Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Recombinant Hepatitis B Vaccine Distributors List
8.3 Recombinant Hepatitis B Vaccine Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Recombinant Hepatitis B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Type (2021-2026)
10.2 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Application (2021-2026)
10.3 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Region (2021-2026)
10.4 North America Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.5 Europe Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Recombinant Hepatitis B Vaccine Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant Hepatitis B Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Recombinant Hepatitis B Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Recombinant Hepatitis B Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Recombinant Hepatitis B Vaccine Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Recombinant Hepatitis B Vaccine Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Recombinant Hepatitis B Vaccine Players to Combat Covid-19 Impact
Table 9. Global Key Recombinant Hepatitis B Vaccine Manufacturers Covered in This Study
Table 10. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Recombinant Hepatitis B Vaccine Sales Share by Manufacturers (2015-2020)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Recombinant Hepatitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Recombinant Hepatitis B Vaccine Sales Sites and Area Served
Table 16. Manufacturers Recombinant Hepatitis B Vaccine Product Types
Table 17. Global Recombinant Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Recombinant Hepatitis B Vaccine Players
Table 21. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Region (2015-2020)
Table 22. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Table 23. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) by Region (2015-2020)
Table 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Table 25. North America Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 26. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 27. North America Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 29. Europe Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 30. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 31. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Table 37. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 38. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 39. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 45. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Type (2015-2020)
Table 46. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2015-2020)
Table 47. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) by Type (2015-2020)
Table 48. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2015-2020)
Table 49. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Type (2015-2020)
Table 50. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2015-2020)
Table 51. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
Table 52. Global Recombinant Hepatitis B Vaccine Sales Growth Rate by Application (2015-2020)
Table 53. Merck Recombinant Hepatitis B Vaccine Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Corporation Information
Table 59. GlaxoSmithKline Plc Corporation Information
Table 60. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. GlaxoSmithKline Plc Main Product
Table 62. GlaxoSmithKline Plc Recent Development
Table 63. Pfizer Inc. Recombinant Hepatitis B Vaccine Corporation Information
Table 64. Pfizer Inc. Corporation Information
Table 65. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Pfizer Inc. Main Product
Table 67. Pfizer Inc. Recent Development
Table 68. Sanofi Pasteur Recombinant Hepatitis B Vaccine Corporation Information
Table 69. Sanofi Pasteur Corporation Information
Table 70. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Sanofi Pasteur Main Product
Table 72. Sanofi Pasteur Recent Development
Table 73. CSL Limited Recombinant Hepatitis B Vaccine Corporation Information
Table 74. CSL Limited Corporation Information
Table 75. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. CSL Limited Main Product
Table 77. CSL Limited Recent Development
Table 78. Emergent Biosolutions Recombinant Hepatitis B Vaccine Corporation Information
Table 79. Emergent Biosolutions Corporation Information
Table 80. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Emergent Biosolutions Main Product
Table 82. Emergent Biosolutions Recent Development
Table 83. Serum Institute of India Recombinant Hepatitis B Vaccine Corporation Information
Table 84. Serum Institute of India Corporation Information
Table 85. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Serum Institute of India Main Product
Table 87. Serum Institute of India Recent Development
Table 88. Johnson & Johnson Recombinant Hepatitis B Vaccine Corporation Information
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Main Product
Table 92. Johnson & Johnson Recent Development
Table 93. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Corporation Information
Table 94. Hualan Biological Engineering Corporation Information
Table 95. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Hualan Biological Engineering Main Product
Table 97. Hualan Biological Engineering Recent Development
Table 98. NCPC Recombinant Hepatitis B Vaccine Corporation Information
Table 99. NCPC Corporation Information
Table 100. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. NCPC Main Product
Table 102. NCPC Recent Development
Table 103. China National Biotec Group Recombinant Hepatitis B Vaccine Corporation Information
Table 104. China National Biotec Group Corporation Information
Table 105. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. China National Biotec Group Main Product
Table 107. China National Biotec Group Recent Development
Table 108. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Corporation Information
Table 109. Dalian Hissen Bio-pharm Corporation Information
Table 110. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Dalian Hissen Bio-pharm Main Product
Table 112. Dalian Hissen Bio-pharm Recent Development
Table 113. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Corporation Information
Table 114. Beijing Tiantan Biological Corporation Information
Table 115. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Beijing Tiantan Biological Main Product
Table 117. Beijing Tiantan Biological Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Recombinant Hepatitis B Vaccine Distributors List
Table 121. Recombinant Hepatitis B Vaccine Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 126. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 130. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 132. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 1. Global Recombinant Hepatitis B Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Recombinant Hepatitis B Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Recombinant Hepatitis B Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Recombinant Hepatitis B Vaccine Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Recombinant Hepatitis B Vaccine Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Recombinant Hepatitis B Vaccine Players to Combat Covid-19 Impact
Table 9. Global Key Recombinant Hepatitis B Vaccine Manufacturers Covered in This Study
Table 10. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Recombinant Hepatitis B Vaccine Sales Share by Manufacturers (2015-2020)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Recombinant Hepatitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Recombinant Hepatitis B Vaccine Sales Sites and Area Served
Table 16. Manufacturers Recombinant Hepatitis B Vaccine Product Types
Table 17. Global Recombinant Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Recombinant Hepatitis B Vaccine Players
Table 21. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Region (2015-2020)
Table 22. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Table 23. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) by Region (2015-2020)
Table 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Table 25. North America Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 26. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 27. North America Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 29. Europe Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 30. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 31. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Table 37. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 38. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 39. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2015-2020)
Table 45. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Type (2015-2020)
Table 46. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2015-2020)
Table 47. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) by Type (2015-2020)
Table 48. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2015-2020)
Table 49. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Type (2015-2020)
Table 50. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2015-2020)
Table 51. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
Table 52. Global Recombinant Hepatitis B Vaccine Sales Growth Rate by Application (2015-2020)
Table 53. Merck Recombinant Hepatitis B Vaccine Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Corporation Information
Table 59. GlaxoSmithKline Plc Corporation Information
Table 60. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. GlaxoSmithKline Plc Main Product
Table 62. GlaxoSmithKline Plc Recent Development
Table 63. Pfizer Inc. Recombinant Hepatitis B Vaccine Corporation Information
Table 64. Pfizer Inc. Corporation Information
Table 65. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Pfizer Inc. Main Product
Table 67. Pfizer Inc. Recent Development
Table 68. Sanofi Pasteur Recombinant Hepatitis B Vaccine Corporation Information
Table 69. Sanofi Pasteur Corporation Information
Table 70. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Sanofi Pasteur Main Product
Table 72. Sanofi Pasteur Recent Development
Table 73. CSL Limited Recombinant Hepatitis B Vaccine Corporation Information
Table 74. CSL Limited Corporation Information
Table 75. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. CSL Limited Main Product
Table 77. CSL Limited Recent Development
Table 78. Emergent Biosolutions Recombinant Hepatitis B Vaccine Corporation Information
Table 79. Emergent Biosolutions Corporation Information
Table 80. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Emergent Biosolutions Main Product
Table 82. Emergent Biosolutions Recent Development
Table 83. Serum Institute of India Recombinant Hepatitis B Vaccine Corporation Information
Table 84. Serum Institute of India Corporation Information
Table 85. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Serum Institute of India Main Product
Table 87. Serum Institute of India Recent Development
Table 88. Johnson & Johnson Recombinant Hepatitis B Vaccine Corporation Information
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Johnson & Johnson Main Product
Table 92. Johnson & Johnson Recent Development
Table 93. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Corporation Information
Table 94. Hualan Biological Engineering Corporation Information
Table 95. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Hualan Biological Engineering Main Product
Table 97. Hualan Biological Engineering Recent Development
Table 98. NCPC Recombinant Hepatitis B Vaccine Corporation Information
Table 99. NCPC Corporation Information
Table 100. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. NCPC Main Product
Table 102. NCPC Recent Development
Table 103. China National Biotec Group Recombinant Hepatitis B Vaccine Corporation Information
Table 104. China National Biotec Group Corporation Information
Table 105. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. China National Biotec Group Main Product
Table 107. China National Biotec Group Recent Development
Table 108. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Corporation Information
Table 109. Dalian Hissen Bio-pharm Corporation Information
Table 110. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. Dalian Hissen Bio-pharm Main Product
Table 112. Dalian Hissen Bio-pharm Recent Development
Table 113. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Corporation Information
Table 114. Beijing Tiantan Biological Corporation Information
Table 115. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Beijing Tiantan Biological Main Product
Table 117. Beijing Tiantan Biological Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Recombinant Hepatitis B Vaccine Distributors List
Table 121. Recombinant Hepatitis B Vaccine Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 126. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 130. Global Recombinant Hepatitis B Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 132. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Recombinant Hepatitis B Vaccine
Figure 2. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. 10mcg/ml Product Picture
Figure 4. 10mcg/0.5ml Product Picture
Figure 5. Global Recombinant Hepatitis B Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Global Recombinant Hepatitis B Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Recombinant Hepatitis B Vaccine Sales Capacity (K Units) (2015-2026)
Figure 11. Global Recombinant Hepatitis B Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Recombinant Hepatitis B Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Recombinant Hepatitis B Vaccine Revenue in 2019
Figure 15. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2019
Figure 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 21. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2019
Figure 40. China Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. UAE Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. UAE Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Recombinant Hepatitis B Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Recombinant Hepatitis B Vaccine by Type in 2019
Figure 80. Revenue Share of Recombinant Hepatitis B Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Recombinant Hepatitis B Vaccine by Type in 2019
Figure 82. Global Recombinant Hepatitis B Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Recombinant Hepatitis B Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Recombinant Hepatitis B Vaccine by Application in 2020
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. NCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Dalian Hissen Bio-pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Beijing Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine
Figure 102. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 103. Recombinant Hepatitis B Vaccine Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. North America Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
Figure 1. Picture of Recombinant Hepatitis B Vaccine
Figure 2. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. 10mcg/ml Product Picture
Figure 4. 10mcg/0.5ml Product Picture
Figure 5. Global Recombinant Hepatitis B Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Global Recombinant Hepatitis B Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Recombinant Hepatitis B Vaccine Sales Capacity (K Units) (2015-2026)
Figure 11. Global Recombinant Hepatitis B Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Recombinant Hepatitis B Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Recombinant Hepatitis B Vaccine Revenue in 2019
Figure 15. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2019
Figure 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 21. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2019
Figure 40. China Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. UAE Recombinant Hepatitis B Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. UAE Recombinant Hepatitis B Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Recombinant Hepatitis B Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Recombinant Hepatitis B Vaccine by Type in 2019
Figure 80. Revenue Share of Recombinant Hepatitis B Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Recombinant Hepatitis B Vaccine by Type in 2019
Figure 82. Global Recombinant Hepatitis B Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Recombinant Hepatitis B Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Recombinant Hepatitis B Vaccine by Application in 2020
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. NCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Dalian Hissen Bio-pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Beijing Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine
Figure 102. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 103. Recombinant Hepatitis B Vaccine Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. North America Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Recombinant Hepatitis B Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Recombinant Hepatitis B Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
